Australia's CSL said on Wednesday it has granted Eli Lilly certain rights to develop and commercialize clazakizumab, an ...

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

This history of rapid acceleration suggests that Eli Lilly is primed for another massive breakout as new catalysts emerge.

(Corrects headline to remove incorrect reference to CSL licensing Eli Lilly's clazakizumab) Feb 18 (Reuters) - Australia's ...

Lilly shares are up more than 400% over the past five years, which trounces the broader market -- the S&P 500 index has ...

Shaquille O'Neal is serving as the ambassador for Eli Lilly and Company's new commitment to U.S.A. athletes for their ...

As with so much of Lilly’s recent advertising work, Wieden+Kennedy’s specific style and tone have helped differentiate its commercials from that of other pharma companies.

Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

Pharmaceutical giant Eli Lilly announced in December at a program at the Von Braun Center that it plans to invest $6 billion in a Huntsville campus and create 450 high-paying jobs. The campus will be ...

Eli Lilly (LLY) stock announced seventh Innovent partnership with $350M upfront and $8.5B milestone potential for joint ...

The investment supports Eli Lilly and Company’s $3.5 billion expansion into Upper Macungie Township, marking the largest private-sector investment in Lehigh Valley history.